Skip to content
← Full study record

NCT01265433 · OUTCOME

Progression-free Survival

Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy · Source last updated 2024-10-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
months
Interval / dispersion
95% Confidence Interval
Time frame
Up to 5 years and 11 months

What was measured

Median progression free survival (PFS) is where PFS are assessed from the time of randomization to first evidence of disease recurrence or death of any cause.

Groups in this outcome

Galinpepimut-S

Galinpepimut-S + Montanide + GM-CSF

Control

Montanide + GM-CSF

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Galinpepimut-S20
Control21

Reported measurements

Source class 1
Values in months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Galinpepimut-S10.1Not reported5.520.8Not reported
Control7.4Not reported2.814.6Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        5.5
        upper Limit
        20.8
        value
        10.1
      2. group Id
        OG001
        lower Limit
        2.8
        upper Limit
        14.6
        value
        7.4
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    2. group Id
      OG001
      value
      21
    units
    Participants
description
Median progression free survival (PFS) is where PFS are assessed from the time of randomization to first evidence of disease recurrence or death of any cause.
dispersion Type
95% Confidence Interval
groups
  1. description
    Galinpepimut-S + Montanide + GM-CSF
    id
    OG000
    title
    Galinpepimut-S
  2. description
    Montanide + GM-CSF
    id
    OG001
    title
    Control
param Type
MEDIAN
reporting Status
POSTED
time Frame
Up to 5 years and 11 months
title
Progression-free Survival
type
PRIMARY
unit Of Measure
months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice